Investor Day Provides Clarity on Centene’s Massive Guidance Cut
Looming problems in the Kentucky and Texas area recently forced Centene (NYSE: CNC ) to slice guidance by 43%. Earlier this week, the multi-line healthcare enterprise made the decision to reduce 2012 EPS estimates ahead of its second quarter earnings call, and it was not the first medical company…
Read the rest of this article on Perspectives Content Submission